Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

A team of scientists from the USA and Canada has recently characterized the antibodies developed against severe acute respiratory syndrome

Read more

Worse problems with SARS-CoV-2 variants may be on the way

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), continues to spread globally.

Read more

Live attenuated SARS-CoV-2 vaccine candidate shows protective efficacy in vivo

With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, the coronavirus disease 2019 (COVID-19) pandemic

Read more